{
    "2020-01-30": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Biogen touts ‘resilience’ but gives little guidance on Alzheimer's drug",
                "features": {
                    "keywords": [
                        "Biogen",
                        "resilience",
                        "Alzheimer's",
                        "guidance"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Biogen Stock Gets a Lift From Strong Earnings Report",
                "features": {
                    "keywords": [
                        "Biogen",
                        "Stock",
                        "Lift",
                        "Strong",
                        "Earnings"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-15",
                "original_text": "Roche (RHHBY) 2019 Sales Solid on Robust Show by New Drugs",
                "features": {
                    "keywords": [
                        "Roche",
                        "Sales",
                        "Solid",
                        "Robust",
                        "New Drugs"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}